Sangamo Announces AAV Capsid Data

Uncategorized

Sangamo Therapeutics Announces Second Quarter 2023 Conference Call and Webcast

BRISBANE, Calif. --(BUSINESS WIRE)--Aug. 1, 2023-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its second quarter 2023 financial results after the market closes on Tuesday, August 8, 2023 .